Bivalirudin Intravenous and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Bivalirudin Intravenous and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bivalirudin
Brand name: Angiomax
Synonyms: Bivalirudin
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bivalirudin Intravenous-Insulin degludec
- Bivalirudin Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Bivalirudin Intravenous-Insulin Degludec (U-100) Vials
- Bivalirudin Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Bivalirudin Intravenous-Insulin degludec and liraglutide
- Bivalirudin Intravenous-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Bivigam
- Insulin aspart, recombinant Subcutaneous-Black Cohosh
- Insulin aspart, recombinant Subcutaneous-Black Draught
- Insulin aspart, recombinant Subcutaneous-Blenoxane
- Insulin aspart, recombinant Subcutaneous-Bleo 15k
- Insulin aspart, recombinant Subcutaneous-Bleomycin